- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/81 - Inhibiteurs de protéase
Détention brevets de la classe C07K 14/81
Brevets de cette classe: 1181
Historique des publications depuis 10 ans
|
72
|
91
|
73
|
76
|
94
|
96
|
80
|
73
|
76
|
55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1158 |
35 |
| Angiochem Inc. | 42 |
25 |
| Daiichi Sankyo Company, Limited | 1877 |
20 |
| Avacta Life Sciences Limited | 36 |
19 |
| Translate bio, Inc. | 413 |
19 |
| The Regents of the University of California | 20289 |
18 |
| Takeda Pharmaceutical Company Limited | 2717 |
17 |
| Cytonics Corporation | 24 |
15 |
| Sanofi Aatd Inc. | 17 |
15 |
| Serpin Pharma, LLC | 23 |
14 |
| CSL Behring GmbH | 346 |
13 |
| Biotissue Holdings Inc. | 82 |
12 |
| Genentech, Inc. | 4015 |
11 |
| ProThera Biologics, Inc. | 22 |
10 |
| Clara Foods Co., AKA Clara Foods | 104 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6535 |
9 |
| Omeros Corporation | 309 |
9 |
| 3B Pharmaceuticals GmbH | 47 |
8 |
| University of Massachusetts | 2257 |
8 |
| Azitra, Inc. | 42 |
8 |
| Autres propriétaires | 886 |